Japanese Phase 1 Multiple Ascending Dose (MAD) Study
Japanese Phase 1 Multiple Ascending Dose (MAD) Study
The purpose of this clinical study is to assess the safety and tolerability of multiple oral
 doses of BMS-820836 in healthy Japanese subjects and Japanese patients with depression.
Inclusion Criteria:

 -  Healthy Japanese subjects and Japanese patients with depression (Hamilton Rating Scale
 for Depression (HAM-D) ≥ 14), ages 20 to 55 years.

 Exclusion Criteria:

 -  Any significant acute or chronic medical illness.

 -  Non-compliance, or overall not suitable as determined by the investigator.

 -  History of, or current clinically significant psychiatric disorders or illnesses,
 substance abuse or dependence.